e.g. mhealth
Search Results (1 to 7 of 7 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 3 JMIR Research Protocols
- 2 JMIR Cardio
- 2 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Formative Research
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)

Patients were eligible if they were aged >18 years and had one or more of the following conditions: hypertension (HT; ICD-10 code I10-I16), diabetes mellitus (DM; ICD-10 code E08-E13), dyslipidemia (DLP; ICD-10 code E78), and atrial fibrillation (AF; ICD-10 code I48). Patients were excluded if they had a stroke on their first visit or only had one visit during the study period.
JMIR Cardio 2025;9:e50627
Download Citation: END BibTex RIS

The major CVD risk factors are physical inactivity, obesity, diabetes mellitus (DM), dyslipidemia, and hypertension, with a prevalence ranging from 11% for DM to 75% for physical inactivity among US adults [1,2,4-8]. Half of US adults have 1 or more CVD risk factors [4-8]. Professional guidelines recommend lifestyle modifications, notably physical activity (PA) and diet, as critical first steps to prevent and treat CVD and its risk factors [2,9-11].
J Med Internet Res 2024;26:e51321
Download Citation: END BibTex RIS

DIA: diabetes without hypertension or dyslipidemia; DIAHD: diabetes with hypertension and dyslipidemia; HEA: healthy or subhealthy; PRE: prediabetes without hypertension or dyslipidemia; PREHD: prediabetes with hypertension and dyslipidemia; TCM: traditional Chinese medicine.
To ensure a sufficient sample size for statistical analysis of the diabetic and prediabetic syndrome differentiation, we intend to recruit 250 participants who will be equally assigned to one of 5 arms.
JMIR Res Protoc 2024;13:e56024
Download Citation: END BibTex RIS

The research question is “Can supplementation with vitamin D improve inflammation and ameliorate dyslipidemia in T2 D?” This protocol will subscribe to PICO guidelines [26]. Participants are adult patients with T2 D. The intervention will be vitamin D supplementations of any dose, and the comparators are placebo or healthy patients without treatment.
The outcomes are inflammation and dyslipidemia, and the study design includes RCTs.
JMIR Res Protoc 2023;12:e42193
Download Citation: END BibTex RIS

In order to better understand how the dyslipidemia status changed over time, we calculated the percent of participants by category of change in the dyslipidemia status from the beginning to the end of the program as follows: dyslipidemia to normal, normal to dyslipidemia, dyslipidemia to dyslipidemia, and normal to normal.
JMIR Cardio 2021;5(1):e28392
Download Citation: END BibTex RIS

The research question is based on the Population, Intervention, Control, Outcome, and Time (PICOT) criteria: In patients with diabetes, hypertension or dyslipidemia, what is the evidence for the effectiveness of telemedicine-supported chronic care on disease-specific clinical outcomes?
J Med Internet Res 2020;22(3):e16791
Download Citation: END BibTex RIS

Dyslipidemia is an important modifiable risk factor for atherosclerotic cardiovascular disease and was the risk factor with the highest population attributable risk in the INTERHEART (Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction) study [4,5].
The prevalence of dyslipidemia in Africa in general and South Africa specifically is increasing and is probably related to lifestyle changes secondary to rapid urbanization [4,6,7].
JMIR Res Protoc 2018;7(6):e163
Download Citation: END BibTex RIS